BRIEF published on 04/10/2025 at 19:05, 1 year ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
BRIEF published on 02/17/2025 at 08:05, 1 year 2 months ago TME Pharma Outlines 2025 Strategic Roadmap and Initiatives Strategic Partnerships Biotechnology Drug Discovery Cancer Therapy NOX-A12
PRESS RELEASE published on 02/17/2025 at 08:00, 1 year 2 months ago Inside Information / Other news releases TME Pharma CEO Aram Mangasarian outlines key initiatives and milestones for 2025, including strategic partnerships, NOX-A12 clinical development, AI-driven drug discovery, and financial updates Strategic Partnerships Clinical Development CEO Message TME Pharma 2025 Initiatives
BRIEF published on 01/29/2025 at 08:05, 1 year 3 months ago TME Pharma and aimed analytics: Innovative partnership for drug discovery through AI Biotechnology Artificial Intelligence Partnership Cancer Drugs
PRESS RELEASE published on 01/29/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases TME Pharma collaborates with aimed analytics for AI-driven drug discovery, strengthening capabilities for strategic transactions. The partnership utilizes AI to accelerate drug development and optimize existing therapies Strategic Partnerships Cancer Treatment TME Pharma AI-driven Drug Discovery Aimed Analytics
BRIEF published on 12/23/2024 at 21:09, 1 year 4 months ago Successful public offering of TME Pharma NV Shareholders Capital Increase Cancer Financial Strategies NOX-A12
BRIEF published on 12/04/2024 at 19:55, 1 year 5 months ago TME Pharma Announces Strategic Update and €2.6 Million Financing Plan Public Offer Corporate Strategy Financing Plan NOX-A12 Development Shareholder Priority
PRESS RELEASE published on 12/04/2024 at 19:50, 1 year 5 months ago Inside Information / Other news releases TME Pharma announces corporate strategy update with upcoming €2.6 million financing aimed at further developing therapies for cancer treatment through public offer open to shareholders. CEO Mangasarian highlights strategic goals and plans Financing Cancer Treatment Public Offer Corporate Strategy TME Pharma
BRIEF published on 11/23/2024 at 10:59, 1 year 5 months ago TME Pharma Presents Findings on NOX-A12 in Glioblastoma Cancer Therapy Glioblastoma NOX-A12 Immune Checkpoint Inhibition Tumor Microenvironment
Published on 05/06/2026 at 13:30, 19 minutes ago Alset AI Acquires Chaco Minerals Debenture Adding Approximately $1.3 Million Investment to Balance Sheet to Offset Lyken.AI Receivables and Strengthen Investment Portfolio
Published on 05/06/2026 at 13:30, 19 minutes ago Gold Basin Resources Announces Settlement Agreement with Charrua Capital LLC
Published on 05/06/2026 at 13:00, 49 minutes ago Sun Peak Metals Commences Maiden Drill Program at Safra VMS Project, Saudi Arabia
Published on 05/06/2026 at 12:00, 1 hour 49 minutes ago ROM Awarded Custom Tracking Contract in the Middle East
Published on 05/06/2026 at 12:00, 1 hour 49 minutes ago Lobe Sciences Reports Second Quarter 2026 Results and Highlights Continued Operational Progress
Published on 05/06/2026 at 13:05, 43 minutes ago Cataneo GmbH Announces Expansion into the $300B U.S. Advertising Market Through Strategic Merger
Published on 05/06/2026 at 12:21, 1 hour 27 minutes ago Hello Paris achieves successful train path ordering for 2027 timetable with IVU.rail
Published on 05/06/2026 at 11:38, 2 hours 11 minutes ago Drägerwerk AG & Co. KGaA: No vote on items 7 and 8 of the agenda at the Annual Shareholders’ Meeting on May 8, 2026 - Cancellation of the separate meeting of preferred shareholders
Published on 05/06/2026 at 10:45, 3 hours 4 minutes ago Thailand Approves $29 Billion Investment Wave as Data Center Demand Surges
Published on 05/06/2026 at 10:00, 3 hours 49 minutes ago 2026 Pacific Ocean International Festival of Rock Balancing and Arts Holds Grand Opening at Qixingtan Scenic Area on May 1st
Published on 05/06/2026 at 10:09, 3 hours 40 minutes ago Guillemot Corporation : Information regarding the total number of voting rights and shares 30/04/2026
Published on 05/06/2026 at 08:42, 5 hours 7 minutes ago Disclosure of shares outstanding and voting rights - 06.05.2026
Published on 05/05/2026 at 19:00, 18 hours 49 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:03, 19 hours 45 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
